Trademark Overview
On Friday, August 15, 2025, a trademark application was filed for BLYSVIA with the United States Patent and Trademark Office. The USPTO has given the BLYSVIA trademark a serial number of 99340293. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, August 15, 2025. This trademark is owned by DBV TECHNOLOGIES. The BLYSVIA trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:
Transdermal patches; adhesive skin patches for medical use; transdermal and adhesive skin patches for treating, alleviating or preventing the development or progression of allergies or immunological disorders; transdermal and adhesive skin patches for the transdermal delivery of pharmaceuticals or medical preparations; patches or epicutaneous systems for cutaneous or epicutaneous administration of medical or pharmaceutical substances for treating allergies or immunological disorders; adhesive patches or adhesive epicutaneous systems for cutaneous or epicutaneous administration of medical or pharmaceutical substances for treating allergies or immunological disorders; occlusive patches or occlusive epicutaneous systems for cutaneous or epicutaneous administration of powdered medical or pharmaceutical substances for treating allergies or immunological disorders; patches or epicutaneous systems containing a powdered preparation for medical or pharmaceutical use for treating allergies or im...
Pads and skin patches for medical training purposes; pads and skin patches for medical use, namely for use in training medical professionals on the transdermal delivery of pharmaceuticals or medical preparations; parts and fittings for all the aforesaid goods